<p>A. Correlation between the total HIV-specific responses determined by direct ex-vivo ELISpot analysis (as spot-forming cells (SFC)/10<sup>6</sup> PBMC) and by ICS analysis (% of IFN-γ<sup>+</sup> CD8<sup>+</sup> T cells). Linear regression line, and correlation coefficient and p-values (Spearman's rank correlation test) are shown. B. The change in total HIV-specific CD8<sup>+</sup> T cell frequency over time by ICS analysis. Horizontal lines indicate median values of all positive responses. P values were determined by Mann-Whitney tests and shown if the significance remains after Bonferroni correction. C, D. Effector function profiles of HIV-specific CD8<sup>+</sup> T cells over time in controls and MVC treated subjects. (left, baseline;...
<p>(A) Proportions of CD4 (upper plots) and CD8 (lower plots) T cells specific for the indicated HIV...
A. Heat map of the weight of the variables included in the Component 1 of the Principal Component An...
<div><p>A. Absolute CD4+ T cell counts at baseline (n=485 and n=216) and 3 (n=369 and n=180), 6 (n=3...
<p>a. Gating scheme used for the identification of CD8<sup>+</sup> T-cell responses. Data shown were...
<p>The total magnitude (A) and breadth (B) of ELISpot responses at baseline (BL), week 24 (w24) and ...
<p><b>A.</b> Longitudinal analysis of the CD4 T-cell counts and HIV viremia of 2 representative HIV-...
<p>Antiviral CD8<sup>+</sup> T-cell capacity measured at 12-months post-infection versus percentage ...
A significant reduction of the CD4+ Tscm pool and no changes in the CD8+ Tscm subset was measured in...
<p>Baseline CD4 T-cell counts (A), immune set point (B) and baseline immune activation (C) versus pr...
<p>a. Correlation between the CD8<sup>+</sup> T-cell functionalities and blood CD4<sup>+</sup>T-cell...
<p>(A) Longitudinal analysis from baseline (same day as ART initiation) and 6 months post ART for to...
<p>Frequencies of HIV-1-specific CD8 T cells (directed against Env+Gag+GPN) that mobilize CD107a and...
<div><p>(A–D) Magnitude and breadth of increase of HIV-specific CD8+ T cells during supervised treat...
<p>The panels show the percentage of T-cells releasing IFN-γ (A) and IL-2 (B) for CD4+ T-cells, and ...
<p>At baseline (Panel A), frequencies of CD38<sup>+</sup>HLA-DR<sup>+</sup> CD8 T cells were compare...
<p>(A) Proportions of CD4 (upper plots) and CD8 (lower plots) T cells specific for the indicated HIV...
A. Heat map of the weight of the variables included in the Component 1 of the Principal Component An...
<div><p>A. Absolute CD4+ T cell counts at baseline (n=485 and n=216) and 3 (n=369 and n=180), 6 (n=3...
<p>a. Gating scheme used for the identification of CD8<sup>+</sup> T-cell responses. Data shown were...
<p>The total magnitude (A) and breadth (B) of ELISpot responses at baseline (BL), week 24 (w24) and ...
<p><b>A.</b> Longitudinal analysis of the CD4 T-cell counts and HIV viremia of 2 representative HIV-...
<p>Antiviral CD8<sup>+</sup> T-cell capacity measured at 12-months post-infection versus percentage ...
A significant reduction of the CD4+ Tscm pool and no changes in the CD8+ Tscm subset was measured in...
<p>Baseline CD4 T-cell counts (A), immune set point (B) and baseline immune activation (C) versus pr...
<p>a. Correlation between the CD8<sup>+</sup> T-cell functionalities and blood CD4<sup>+</sup>T-cell...
<p>(A) Longitudinal analysis from baseline (same day as ART initiation) and 6 months post ART for to...
<p>Frequencies of HIV-1-specific CD8 T cells (directed against Env+Gag+GPN) that mobilize CD107a and...
<div><p>(A–D) Magnitude and breadth of increase of HIV-specific CD8+ T cells during supervised treat...
<p>The panels show the percentage of T-cells releasing IFN-γ (A) and IL-2 (B) for CD4+ T-cells, and ...
<p>At baseline (Panel A), frequencies of CD38<sup>+</sup>HLA-DR<sup>+</sup> CD8 T cells were compare...
<p>(A) Proportions of CD4 (upper plots) and CD8 (lower plots) T cells specific for the indicated HIV...
A. Heat map of the weight of the variables included in the Component 1 of the Principal Component An...
<div><p>A. Absolute CD4+ T cell counts at baseline (n=485 and n=216) and 3 (n=369 and n=180), 6 (n=3...